Product NDC: | 53489-590 |
Proprietary Name: | Cyclobenzaprine Hydrochloride |
Non Proprietary Name: | Cyclobenzaprine Hydrochloride |
Active Ingredient(s): | 5 mg/1 & nbsp; Cyclobenzaprine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 53489-590 |
Labeler Name: | Mutual Pharmaceutical |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA073541 |
Marketing Category: | ANDA |
Start Marketing Date: | 19950523 |
Package NDC: | 53489-590-05 |
Package Description: | 500 TABLET, FILM COATED in 1 BOTTLE (53489-590-05) |
NDC Code | 53489-590-05 |
Proprietary Name | Cyclobenzaprine Hydrochloride |
Package Description | 500 TABLET, FILM COATED in 1 BOTTLE (53489-590-05) |
Product NDC | 53489-590 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cyclobenzaprine Hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 19950523 |
Marketing Category Name | ANDA |
Labeler Name | Mutual Pharmaceutical |
Substance Name | CYCLOBENZAPRINE HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |